Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Journal Article
Number of items: 4.

Journal Article

Armaroli, Giulia, Klein, Ariane, Ganser, Gerd, Ruehlmann, Michael J., Dressler, Frank, Hospach, Anton, Minden, Kirsten, Trauzeddel, Ralf, Foeldvari, Ivan, Kuemmerle-Deschner, Jasmin, Weller-Heinemann, Frank, Urban, Andreas and Horneff, Gerd (2020). Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry. Arthritis Res. Ther., 22 (1). LONDON: BMC. ISSN 1478-6362

Klein, Ariane, Klotsche, Jens, Huegle, Boris, Minden, Kirsten, Hospach, Anton, Weller-Heinemann, Frank, Schwarz, Tobias, Dressler, Frank, Trauzeddel, Ralf, Hufnagel, Markus, Foeldvari, Ivan, Borte, Michael, Kuemmerle-Deschner, Jasmin, Brunner, Juergen, Oommen, Prasad Thomas, Foell, Dirk, Tenbrock, Klaus, Urban, Andreas and Horneff, Gerd (2020). Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry. RHEUMATOLOGY, 59 (9). S. 2287 - 2299. OXFORD: OXFORD UNIV PRESS. ISSN 1462-0332

Klein, Ariane, Minden, Kirsten, Hospach, Anton, Foeldvari, Ivan, Weller-Heinemann, Frank, Trauzeddel, Ralf, Huppertz, Hans-Iko and Horneff, Gerd (2020). Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis. Ann. Rheum. Dis., 79 (7). S. 969 - 975. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

Ruperto, Nicolino ORCID: 0000-0001-8407-7782, Brunner, Hermine I., Quartier, Pierre, Constantin, Tamas, Wulffraat, Nico M., Horneff, Gerd, Kasapcopur, Ozgur ORCID: 0000-0002-1125-7720, Schneider, Rayfel, Anton, Jordi ORCID: 0000-0002-8792-4219, Barash, Judith, Berner, Reinhard ORCID: 0000-0002-6216-9173, Corona, Fabrizia, Cuttica, Ruben, Fouillet-desjonqueres, Marine, Fischbach, Michel, Foster, Helen E., Foell, Dirk, Radominski, Sebastiao C., Ramanan, Athimalaipet V., Trauzeddel, Ralf, Unsal, Erbil, Levy, Jeremy, Vritzali, Eleni, Martini, Alberto and Lovell, Daniel J. (2018). Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials. Ann. Rheum. Dis., 77 (12). S. 1710 - 1720. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

This list was generated on Sun Nov 24 07:04:24 2024 CET.